AcelRx Pharmaceuticals Inc
NASDAQ:ACRX
AcelRx Pharmaceuticals Inc
NASDAQ:ACRX
Price:
1.1277 USD
2.52%
Updated:
May 3, 2024
AcelRx Pharmaceuticals Inc
Cash from Investing Activities
|
AcelRx Pharmaceuticals Inc
Cash from Investing Activities Peer Comparison
Comparables:
JNJ
BMY
PFE
MRK
LLY
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
AcelRx Pharmaceuticals Inc
NASDAQ:ACRX
|
Cash from Investing Activities
$5.8m
|
CAGR 3-Years
-45%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
7%
|
|
|
Johnson & Johnson
NYSE:JNJ
|
Cash from Investing Activities
$878m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Cash from Investing Activities
-$21.7B
|
CAGR 3-Years
-23%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Pfizer Inc
NYSE:PFE
|
Cash from Investing Activities
-$32.3B
|
CAGR 3-Years
-96%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-12%
|
|
|
Merck & Co Inc
NYSE:MRK
|
Cash from Investing Activities
-$14.1B
|
CAGR 3-Years
-18%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-9%
|
|
|
Eli Lilly and Co
NYSE:LLY
|
Cash from Investing Activities
-$7.2B
|
CAGR 3-Years
-47%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-13%
|
See Also
What is AcelRx Pharmaceuticals Inc's Cash from Investing Activities?
Cash from Investing Activities
5.8m
USD
5.8m
USD
Based on the financial report for Sep 30, 2023, AcelRx Pharmaceuticals Inc's Cash from Investing Activities amounts to 5.8m USD.
What is AcelRx Pharmaceuticals Inc's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 10Y
7%
7%
Over the last year, the Cash from Investing Activities growth was -80%. The average annual Cash from Investing Activities growth rates for AcelRx Pharmaceuticals Inc have been -45% over the past three years , and 7% over the past ten years .
You don't have any saved screeners yet
